Amantadine Side Effect Rates
Amantadine causes CNS side effects in approximately 13-14% of patients at standard 200 mg/day dosing (versus 4% with placebo), with gastrointestinal effects occurring in 1-3% of patients, and these rates increase substantially in elderly patients and those with renal impairment who require mandatory dose reduction to prevent serious toxicity. 1, 2
Common Side Effects (Occur in >5% of Patients)
CNS effects are the most frequent adverse reactions:
- Nervousness, anxiety, insomnia, difficulty concentrating, and lightheadedness occur in approximately 13-14% of patients taking 200 mg/day 1, 2, 3
- These CNS symptoms are significantly higher than the 4% rate seen with placebo 1, 2
- Nausea is among the most frequently reported adverse reactions at recommended doses 4
- Dizziness (lightheadedness) is common 4
- Insomnia is common 4
Uncommon Side Effects (Occur in 1-5% of Patients)
Gastrointestinal effects are less frequent:
- Nausea and anorexia occur in approximately 1-3% of persons taking amantadine, comparable to placebo rates of 1-2% 1, 2
- Constipation is a less common side effect 4
Rare but Serious Side Effects
Severe CNS toxicity can occur, particularly in high-risk populations:
- Marked behavioral changes, delirium, hallucinations, agitation, and seizures have been observed 1, 2, 4
- These severe effects are associated with high plasma drug concentrations, particularly levels >3000 ng/mL 5, 6
- Acute overdosage can cause CNS, renal, respiratory, and cardiac toxicity including arrhythmias 2
- Acute respiratory failure, pulmonary edema, and adult respiratory distress syndrome (ARDS) are potential complications in acute overdosage 4
Anticholinergic effects:
- Amantadine can cause mydriasis and should not be used in patients with untreated angle-closure glaucoma 2, 4
- Urinary retention is an anticholinergic manifestation 4
Dramatically Increased Risk in Elderly Patients
The side effect profile is substantially worse in elderly patients, necessitating mandatory dose reduction:
- At 200 mg/day (standard adult dose): Serious CNS toxicity occurs most often among elderly persons, particularly women, due to smaller average body size and age-related decline in renal function 1, 2, 4, 5
- At 100 mg/day (maximum elderly dose): CNS-related adverse effects range from 4.9% to 12.5% in elderly patients, with elderly women at higher risk than elderly men 4, 5, 7
- The daily dose for persons aged ≥65 years must not exceed 100 mg for either prophylaxis or treatment due to dose-dependent toxicity 4, 5, 6
- Some elderly persons require further dose reduction below 100 mg/day to minimize serious CNS toxicity 4, 5
Markedly Increased Risk with Renal Impairment
Renal dysfunction dramatically increases side effect rates due to drug accumulation:
- Amantadine is excreted unchanged in the urine by glomerular filtration and tubular secretion; renal clearance is substantially reduced in patients with renal insufficiency 1, 4, 5
- Plasma half-life increases from 11.8 hours in normal renal function to 18.5 hours to 33.8 days in patients with creatinine clearance ranging from 43.1 to 5.9 mL/min 8
- In patients with severe renal impairment, renal clearance decreases from 10,965 to 2,618 mL/h compared to those with normal renal function 9
- Dosage reduction is required for creatinine clearance ≤50 mL/min/1.73m² to prevent accumulation and toxicity 1, 5, 10
- Hemodialysis contributes minimally to drug clearance (less than 5% removed per 4-hour session) 5, 8
High-Risk Populations Requiring Dose Reduction and Close Monitoring
These patients have substantially elevated risk of serious side effects:
- Patients with renal insufficiency (any degree) 1, 2, 4
- Patients with seizure disorders 1, 2, 4
- Patients with certain psychiatric disorders 1, 2, 4
- Elderly persons, especially women 1, 4, 5
- Patients with neuropsychiatric disorders or taking psychotropic drugs 3
Lowering the dosage in these populations significantly reduces the incidence and severity of side effects 1, 2, 4, 5
Time Course and Reversibility
Most side effects follow a predictable pattern:
- Side effects are usually mild and cease soon after discontinuing the drug 1, 2, 4
- Side effects can diminish or disappear after the first week despite continued drug ingestion 1, 2, 4
- However, serious side effects require immediate dose reduction or discontinuation 4, 5
Critical Dosing Algorithm to Minimize Side Effects
For elderly patients (≥65 years):
- Verify renal function before initiating therapy 4, 5
- Start at maximum 100 mg/day (not the standard 200 mg/day dose) 4, 5, 6
- Consider further reduction below 100 mg/day for elderly women, those with any degree of renal impairment, or those with seizure/psychiatric history 4, 5
- Monitor closely for CNS toxicity (confusion, hallucinations, agitation) especially in the first week 4, 5, 6
- Reduce dose or discontinue immediately if serious side effects emerge 4, 5
For patients with renal impairment:
- Creatinine clearance ≤50 mL/min/1.73m²: Mandatory dose reduction required 1, 5
- Creatinine clearance ≤10 mL/min: Consider extended dosing intervals (every 48-168 hours depending on severity) 9
- Observe carefully for adverse reactions after dose adjustment 5
Common Pitfalls to Avoid
The most dangerous error is failing to adjust dose for age and renal function:
- Using standard 200 mg/day dosing in patients ≥65 years instead of the required maximum 100 mg/day significantly increases risk of serious adverse effects 4, 5, 6
- Failing to adjust dose for renal function in elderly patients (who have age-related decline in renal function) dramatically increases toxicity risk 4, 5
- Not recognizing that renal function declines with increasing age, necessitating dose reduction in all elderly patients 4, 5